We also tried to prove that silencing and down-regulation of RIPK3 could regulate CaMKIIδ alternative splicing and CaMKII activity to delay the pathogenesis of cardiac hypertrophy. The gene discussed is CAMK2G; the disease is cardiac hypertrophy.